D-0395-2026 Class II Ongoing
FDA drug recall D-0395-2026 was initiated by New Life Pharma LLC on Feb 26, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 45 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 11, 2026
- Initiation Date
- Feb 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45 vials
Product description
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
OH
Code information
Lot 240709, exp 7/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0395-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026